课题基金 / 基金详情

项目摘要

项目成果

EDWIN M STONE的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Age-related macular degeneration - the most common cause of severe visual loss in the developed world has a significant genetic component. This fact raises the possibility that the expanding knowledge of the human genome can be used to improve our ability to diagnose and treat this disorder. Recently, we demonstrated that mutations in the gene encoding an extracellular matrix protein known as fibulin 5 are responsible for a statistically significant subset of age-related macular degeneration. In this proposal, we will pursue this discovery at four different levels. First we will screen portions of three fibulin genes (2, 5, and 6) in the cohort of AMD patients and controls that were gathered as part of the Age-Related Eye Disease Study (AREDS) to determine whether our previous results can be confirmed in this well characterized group of individuals. We will also use a novel, focused screening approach to evaluate a minimum of 25 other genes whose proteins are functionally related to the fibulins to determine whether any of these are also involved in the pathogenesis of AMD. In addition, we will explore the pathophysiology of fibulin associated AMD at the tissue level by carefully evaluating the eyes of mice with abnormalities in fibulins 2, 3 and 5 as well as by crossing these mice to ABCA4 deficient mice in an attempt to augment their phenotype. Finally, we will carefully study 37 human kindreds already known to harbor mutations in fibulin genes to test the hypothesis that the phenotype we observed in the fibulin 5 patients in our previous study is characteristic of fibulin associated AMD as a whole. This part of the study will also assess the age-dependent penetrance of fibulin mutations in these kindreds, which will be a critical factor in determining whether large scale molecular testing for fibulin variations will someday be of value.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Unraveling the 10q AMD Risk Locus
  • 批准号:
    9762936
  • 项目类别:
  • 资助金额:
    $49.58万
  • 财政年份:
    2016
  • 负责人:
    EDWIN M STONE
  • 依托单位:
CRISPR-Cas9 based treatment of dominant retinal degeneration
  • 批准号:
    10380840
  • 项目类别:
  • 资助金额:
    $37.43万
  • 财政年份:
    2016
  • 负责人:
    EDWIN M STONE
  • 依托单位:
CRISPR-Cas9 based treatment of dominant retinal degeneration
  • 批准号:
    9886365
  • 项目类别:
  • 资助金额:
    $39.49万
  • 财政年份:
    2016
  • 负责人:
    EDWIN M STONE
  • 依托单位:
Unraveling the 10q AMD Risk Locus
  • 批准号:
    9340188
  • 项目类别:
  • 资助金额:
    $49.58万
  • 财政年份:
    2016
  • 负责人:
    EDWIN M STONE
  • 依托单位:
海外基金